/study / lectures / NORA
ECT Anesthesia — Methohexital, Sux, Lithium, Hemodynamic Surge
TEXTNORA · 6 min read
Brief general anesthesia for a controlled seizure. The induction agent must permit the seizure, the relaxant must blunt the motor convulsion, and the cardiovascular surge must not kill the patient.
After this lesson you can
3 min read6 sectionsThe procedure + anesthetic goals
Electroconvulsive therapy (ECT) delivers a brief electrical stimulus (0.5-8 s) via bilateral or right unilateral electrodes to induce a generalized tonic-clonic seizure lasting 25-90 s.
- severe treatment-resistant depression
- catatonia
- suicidal ideation
- severe mania
- NMS
- peripartum psychiatric emergency
- rapid unconsciousness
- amnesia
- attenuation of motor convulsion to prevent injury
- preservation of the cerebral seizure (the therapeutic effect)
- control of the autonomic surge
- prompt emergence
Typical course: 6-12 treatments over 3-4 weeks, then maintenance.
Each session is ~10-15 min from induction to recovery.
Methohexital — the reference induction agent
Methohexital 0.75-1 mg/kg IV is the historical and still-preferred induction agent because it raises seizure threshold less than other agents (allows lower stimulus charge → fewer cognitive side effects).
0.5-1 mg/kg lengthens seizure but raises BP + HR + emergence reactionsModern practice when methohexital unavailable: propofol 0.75-1 mg/kg with acceptance of slightly shorter seizure, or etomidate 0.15-0.3 mg/kg if seizures have been inadequate.
Avoid benzodiazepines (raise threshold + shorten seizure).

Succinylcholine + the cuff/tourniquet trick
Sux 0.5-1 mg/kg IV attenuates the motor convulsion enough to prevent musculoskeletal injury (long-bone fracture historically reported pre-NMB era) while still permitting some visible activity.
Onset 30-60 s; ideal for the brief duration.
To monitor seizure duration when sux is given, inflate a BP cuff or tourniquet on one limb (foot or forearm) to suprasystolic 50 mmHg ABOVE SBP BEFORE giving sux — the limb is excluded from circulation, sux does not reach the muscle, and overt motor seizure activity is visible there.
Deflate when stimulus ends.
EEG monitoring is the alternative + complementary monitor — EEG seizure typically lasts longer than motor seizure.
Hemodynamic surge — biphasic autonomic response
Glycopyrrolate 0.2 mg IV or atropine 0.4-0.6 mg IV pretreatment if history of significant bradycardia, vagal pause >6 s, or in patients on beta-blockers.
Phase 2 (sympathetic, during + immediately after seizure): tachycardia to 130-150, BP rise 30-40%, increased myocardial O2 demand.
In CAD or aneurysm patients, attenuate with esmolol 0.5-1 mg/kg or labetalol 0.1-0.3 mg/kg or remifentanil 1 mcg/kg pre-stimulus.
Avoid excessive blunting — sustained hypotension shortens seizure.
Nitroglycerin paste pretreatment is a simple low-tech option for chronic HTN.
Lithium + medication interactions
Lithium prolongs the duration of both succinylcholine and nondepolarizing NMB paralysis (mechanism: inhibits presynaptic ACh release + alters Na/K flux at NMJ) and prolongs seizure duration.
Many anesthesiologists hold lithium for 24-48 h before ECT or reduce sux dose by ~50% (0.3-0.5 mg/kg).
Document timing of last dose.

Special populations + device considerations
ICDs: deactivate tachy detection with magnet before stimulus (myopotentials from seizure can trigger inappropriate shock); reactivate after.
Pregnancy: ECT is safe in all trimesters and often preferred over medications in severe depression; left-lateral tilt after 20 wk, aspiration prophylaxis (sodium citrate 30 mL PO + ranitidine), continuous FHR monitoring during/after, tocolysis if uterine activity.
- lower methohexital dose (0.5-0.75 mg/kg)
- longer recovery
- increased delirium risk — minimize anticholinergics
Patients with intracranial aneurysm or recent stroke: relative contraindication; aggressive BP control essential.

End of lecture
You just covered ~3 minutes of NORA. Reinforce with a few questions while it's fresh.